Search
Categories


Archive for January, 2007

Pfizer prevails in Norvasc patent suit

Wednesday, January 31st, 2007

U.S. drug powerhouse Pfizer said Wednesday it has prevailed in its patent dispute with Synthon over the anti-hypertension drug Norvasc. (Source: United Press International – Health Business)

Court Rules In Pfizer’s Favor In Norvasc Patent Case, Finds Synthon Obtained Patent By Inequitable Conduct

Wednesday, January 31st, 2007

(Source: Pfizer Media Center – News Releases)

Sepracor tops $1B in revenue for 2006

Wednesday, January 31st, 2007

Sepracor Inc. has hit the billion dollar revenue milestone for the first time, thanks in large part to soaring sales of its anti-insomnia drug Lunesta. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Aripiprazole and Lamictal in Bipolar Depression

Tuesday, January 30th, 2007

Are you suffering from bipolar disorder, also known as manic depressive disorder? If you are, you may be eligible to participate in a research study at Duke University Medical Center, where doctors are testing the safety and effectiveness of an investigational drug to treat the symptoms of depression in bipolar subjects. You will receive study drug and psychiatric evaluations, as well as compensation for your time and expenses. For more information, please call the study coordinator at 919-684-2873. (Source: dukehealth.org: Duke Clinical Trials)

Review: ED drugs can be used by diabetics

Monday, January 29th, 2007

Drugs used to treat erectile dysfunction, such as Viagra, Levitra and Cialis, can be used by men with diabetes, an Israeli review found. (Source: United Press International – Consumer Health)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

ED Drugs Prove Effective, Safe For Men With Diabetes

Saturday, January 27th, 2007

Popular drugs used to treat erectile dysfunction — Viagra, Levitra and Cialis — are safe and effective for men with diabetes, a new review has found.The introduction of the medications known as phosphodiesterase type 5 (PDE-5) inhibitors to the market has changed the way physicians manage their patients with erectile dysfunction. [click link for full article] (Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today)

Viagra-Like Drugs Can Treat Erectile Dysfunction In Men With Diabetes

Friday, January 26th, 2007

Around half of all men with diabetes have at least one episode during the course of their condition when they fail to maintain an erection sufficient for sexual intercourse. Many different strategies have been used to overcome this, but a Cochrane Review of clinical trials shows that three phosphodiesterase type 5 (PDE-5) inhibitors, sildenafil (Viagra), vardenafil (Levitra) and tadalafil (Cialis) increased diabetic men’s satisfaction with their sexual life, compared to placebo. [click link for full article] (Source: Diabetes News From Medical News Today)

Report: Comparative effectiveness of second-generation antidepressants in treatment of adult depression

Wednesday, January 24th, 2007

This report ‘Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression,’ is the newest analysis from the Effective Health Care programme of the Agency for Healthcare Research and Quality (AHRQ) in the U.S. This programme aims to help patients and healthcare practictioners choose the most effective treatments. The analysis examined 293 published studies looking at use of second-generation antidepressants in adults, of which 187 were judged to be of good or fair quality. It compared the drugs’ benefits and risks in the treatment of major depressive disorder, dysthymia (a chronic, less-severe form of depression), and subsyndromal depression (an acute mood disorder that is less severe than major depression). The drugs analysed were …

Levetiracetam (Keppra) now licenced for the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Ideopathic Generalised Epilepsy

Tuesday, January 23rd, 2007

National electronic Library for Medicines (NeLM) (Source: CEBMH News | News Front Page)

Exforge® Approved In Europe As Powerful New Blood Pressure Therapy Combining Two Leading Medications In A Single Pill

Monday, January 22nd, 2007

Novartis announced today that the European Commission has granted approval for Exforge® as a new and highly effective single-pill treatment for patients with high blood pressure. Exforge combines in one tablet the power of the two most commonly prescribed branded hypertension medicines – Diovan (valsartan) and Norvasc (amlodipine besylate). [click link for full article] (Source: Cardiovascular / Cardiology News From Medical News Today)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Page 1 of 3123